Cytokine-regulated production of the major histocompatibility complex class-III-encoded complement proteins factor B and C4 by human glomerular mesangial cells
Local production of complement within normal or diseased kidneys could be of importance during local inflammatory reactions. In the present study, we demonstrate that human MCs are able to synthesize the MHC class-III-encoded complement proteins factor B and C4 in vitro. This synthesis is strongly u...
Saved in:
Published in | Human immunology Vol. 43; no. 1; pp. 19 - 28 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.05.1995
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Local production of complement within normal or diseased kidneys could be of importance during local inflammatory reactions. In the present study, we demonstrate that human MCs are able to synthesize the MHC class-III-encoded complement proteins factor B and C4 in vitro. This synthesis is strongly upregulated following stimulation with cytokine-containing supernatants of activated peripheral blood mononuclear cells. All primary cell lines tested so far are able to synthesize factor B and C4 after stimulation. To determine more specifically whether defined cytokines are able to enhance factor B and C4 complement production, MCs were stimulated with IL-1α, IFN-γ, and TNF-α. Factor B synthesis was increased in a dose-dependent fashion by IL-lα, TNF-α, and IFN-γ, whereas C4 synthesis was only upregulated by IFN-γ. Furthermore, factor B synthesis was upregulated after stimulation with IFN-α, -β, and -γ and C4 synthesis only by IFN-γ. The synthesis of factor B and C4 was inhibited by cycloheximide, suggesting de novo protein synthesis. The cytoplasmic localization of both components was shown by immunofluorescence studies. Northern and dot blot analysis revealed induction of factor B and C4 mRNA after stimulation with cytokines. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0198-8859 1879-1166 |
DOI: | 10.1016/0198-8859(94)00122-7 |